Combination Antiretroviral Therapy (cART) for PBC

Condition:   Primary Biliary Cholangitis Interventions:   Drug: Emtricitabine (FTC)/Tenofovir Disoproxil (TDF);   Drug: Raltegravir;   Drug: Placebo Oral Capsule [CEBOCAP] Sponsors:   University of Alberta;   Merck Sharp & Dohme Corp. Not yet recruiting

Source: ClinicalTrials.gov - May 17, 2019 Category: Research Source Type: clinical trials